Attachment 1: Proteomic Data Commons Data Submission Request Form
OMB
No.: 0925-0775
|
Please complete the following document and send to: PDCHelpDesk@mail.nih.gov.
Please include a narrative describing your study and its scientific benefit for inclusion in the Proteomic Data Commons (PDC).
Please include the following information:
Name/Identifier of Study with a brief description
Grant ID and funding source (if applicable)
IRB approval numbers (if applicable)
Scientific Point of Contact (Name, Phone, Email)
Data Manager Point of Contact (Name, Phone, Email)
Data access policy (choose one):
Open-access – no-embargo
Open-access – embargo
Cancer type(s) included in study
Number of cases included in study (please indicate if demographic and diagnosis data are available)
Information on the Proteomic Data Analysis Protocol
Type of acquisition – DDA, DIA
Experiment type – Label Free, iTRAQ, TMT, etc.
Analytical fractions – Proteome, phosphoproteome, etc.
Instrument make and model
Additional proteomic data analysis protocol including experimental design
Additional data types included in study and experimental strategies used (list all that apply and indicate target repository for additional data types such as the National Cancer Institute’s Genomic Data Commons):
Imaging
Genomics
Immunology
Clinical
Other (specify)
Amount of data (in TB, # of files)
Include description of treatment, relapse/recurrence, and/or outcome data available with this dataset (if applicable)
The overall scientific benefit of including this study in the PDC
Publications associated with this study, if any.
Time constraints on processing/loading/releasing the data to the public
Data standards used, if any.
Please attach (if available):
Data Dictionary
Biospecimen and experiment metadata
Data Model/Schema diagram indicating how collected data relates to subjects, visits, samples, etc.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Kim, Erika (NIH/NCI) [E] |
File Modified | 0000-00-00 |
File Created | 2023-08-02 |